In support of mutp53-Nek2 link in human breast cancer, we found a strong correlation between mutp53 (all mutations, Metabric) and Nek2 mRNA expression compared to patients with wtp53 (Fig. 4f). Here, NEK2 is linked to breast carcinoma.